1. Tang, Jianming, Tian, Xiaoli, Min, Jie, Hu, Ming, Hong, Li. 2022. RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma. In Frontiers in oncology, 12, 957472. doi:10.3389/fonc.2022.957472. https://pubmed.ncbi.nlm.nih.gov/36091104/
2. Dai, Jingyuan, Gao, Jiahui, Dong, Hongchao. 2024. Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma. In Aging, 16, 11162-11184. doi:10.18632/aging.205952. https://pubmed.ncbi.nlm.nih.gov/39012280/
3. Jarrous, N, Eder, P S, Wesolowski, D, Altman, S. . Rpp14 and Rpp29, two protein subunits of human ribonuclease P. In RNA (New York, N.Y.), 5, 153-7. doi:. https://pubmed.ncbi.nlm.nih.gov/10024167/
4. Yang, Yun-Song, Ren, Yi-Xing, Liu, Cheng-Lin, Jiang, Yi-Zhou, Shao, Zhi-Ming. 2022. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target. In Breast cancer research and treatment, 193, 319-330. doi:10.1007/s10549-022-06537-z. https://pubmed.ncbi.nlm.nih.gov/35334008/